Namwiwat Medical PCL (BKK:NAM) Long-Term Debt: ฿81 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:NAM Namwiwat Medical Corp PCL BKK:NAM
39 GF Score
Price ฿3.42
GF Value ฿6.00
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Namwiwat Medical PCL Long-Term Debt?

Namwiwat Medical PCL BKK:NAM +0.59% 39 Long-Term Debt is ฿81 Mil as of Mar. 2026. GuruFocus rates BKK:NAM with a GF Score™ of 39/100 and a GF Value™ of ฿6.00 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Namwiwat Medical PCL's Long-Term Debt for the quarter that ended in Mar. 2026 was ฿81 Mil.

Namwiwat Medical PCL's quarterly Long-Term Debt declined from Sep. 2025 (฿96 Mil) to Dec. 2025 (฿89 Mil) and declined from Dec. 2025 (฿89 Mil) to Mar. 2026 (฿81 Mil).

Namwiwat Medical PCL's annual Long-Term Debt declined from Dec. 2023 (฿75 Mil) to Dec. 2024 (฿34 Mil) but then increased from Dec. 2024 (฿34 Mil) to Dec. 2025 (฿89 Mil).

Namwiwat Medical PCL  (BKK:NAM) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Namwiwat Medical PCL Long-Term Debt Related Terms

Namwiwat Medical PCL Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Namwiwat Medical PCL's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Namwiwat Medical PCL Long-Term Debt Chart

Namwiwat Medical PCL Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial 124.62 96.68 74.68 34.36 88.67

Namwiwat Medical PCL Quarterly Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.41 105.50 95.52 88.67 81.16
BKK:NAM
39GF Score
Namwiwat Medical Corp PCL BKK:NAM
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ฿81 Mil mean?
Namwiwat Medical PCL (BKK:NAM) has a Long-Term Debt of ฿81 Mil as of Mar. 2026.
Is Namwiwat Medical PCL's Long-Term Debt too high?
Namwiwat Medical PCL's current Long-Term Debt is ฿81 Mil. Overall, Namwiwat Medical PCL has a GF Score™ of 39/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Namwiwat Medical PCL's Long-Term Debt compare to ABT and SYK?
Namwiwat Medical PCL's Long-Term Debt of ฿81 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Namwiwat Medical PCL's current Long-Term Debt is ฿81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Namwiwat Medical PCL stock overvalued right now?
Based on GuruFocus' analysis, Namwiwat Medical PCL (BKK:NAM) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿6.00, compared to a current price of ฿3.42 — trading 43% below its estimated fair value. The current Long-Term Debt is ฿81 Mil. Namwiwat Medical PCL's overall GF Score™ is 39/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Namwiwat Medical PCL (BKK:NAM), the current Long-Term Debt is ฿81 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Namwiwat Medical PCL (BKK:NAM) Overvalued in 2026?

Based on GuruFocus' analysis, Namwiwat Medical PCL stock appears to be undervalued. The current stock price of ฿3.42 is trading 43% below its estimated GF Value™ of ฿6.00. GuruFocus considers Namwiwat Medical PCL to be Significantly Undervalued.

Key valuation signals for BKK:NAM:

  • Long-Term Debt: ฿81 Mil
  • GF Value™: ฿6.00 vs. price of ฿3.42 (43% below fair value)
  • GF Score™: 39/100 with 5 warning signs

No single metric tells the full story. See the BKK:NAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Namwiwat Medical PCL Business Description

Address 999/3-5 Moo 9 Prachauthit - Ku Sang Road, Nai Khlong Bang Pla Kot, Phra Samut Chedi, Samut Prakan, THA, 10290
Namwiwat Medical Corp PCL operates a manufacturing business, importing and distributing Medical tools and equipment for cleaning and disinfecting medical equipment in hospitals and nursing homes in accordance with public health standards. The Group has a total of three reporting segments as follows: Medical equipment manufacturing and distribution segment; Medical supplies manufacturing and distribution segment; CSSD disinfection Medical equipment maintenance services segment, and waste services segment. The Group operates its business in one geography, only in Thailand.
39GF Score

Get the complete analysis for BKK:NAM

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿3.42
Price
฿6.00
GF Value